Daniel Auclair/X
Jun 16, 2025, 17:37
Daniel Auclair Highlights GMMG-CONCEPT Study Presentation by Lisa Leypoldt at EHA 2025
Daniel Auclair, President at Hematocure, LLC, posted on X:
“Dr. Lisa Leypoldt (congrats again on Young Investigator Award!) presenting GMMG-CONCEPT study, the largest prospective trial so far of purely HR NDMM, at EHA2025.
Isa-KRd induction/consolidation and Isa-KR maint. produced high rates MRDneg and was well tolerated.”
More posts featuring EHA 2025 on Hemostasis Today.
-
May 27, 2026, 04:47Daniel Torrent: The Overlooked Epidemic of Post-Thrombotic Syndrome
-
May 27, 2026, 04:45Graziella Pompei: Is Aspirin Still a Valid Alternative to Clopidogrel in PCI with DES Implantation?
-
May 27, 2026, 04:40Kausik Ray: Phase 1 Trial Highlights Anti-Inflammatory Effects of Ruvonoflast
-
May 27, 2026, 04:29Francisco Chacón-Lozsán: High-Sensitivity Troponin and the Evolving Management of NSTEMI
-
May 27, 2026, 04:14Michael R. Jaff: HI-PEITHO Trial and NEWS Score Insights on Advances for Intermediate-Risk Pulmonary Embolism
-
May 26, 2026, 16:45Ashley George: Take the Leap for Thrombosis UK
-
May 26, 2026, 16:40Hamed Helisaz: Machine Learning for Detecting Missing Heart Medications
-
May 26, 2026, 15:32Haroun Gajraj: Brown Marks After Microsclerotherapy – What Every Practitioner Needs to Know
-
May 26, 2026, 15:29Jacqueline van Paassen: Lack of Essential Clinical Data in DOAC Prescriptions in Community Pharmacies